Cargando…
Parametric Drug Release Optimization of Anti-Inflammatory Drugs by Gold Nanoparticles for Topically Applied Ocular Therapy
Eye drops represent 90% of all currently used ophthalmic treatments. Only 0.02% of therapeutic molecules contained in eye drops reach the eye anterior chamber despite their high concentration. The tear film efficiently protects the cornea, reducing access to the target. Thereby, the increase in the...
Autores principales: | Raiche-Marcoux, Gabrielle, Loiseau, Alexis, Maranda, Cloé, Poliquin, Audrée, Boisselier, Elodie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786640/ https://www.ncbi.nlm.nih.gov/pubmed/36555830 http://dx.doi.org/10.3390/ijms232416191 |
Ejemplares similares
-
Synthesis of Ultrastable Gold Nanoparticles as a New Drug Delivery System
por: Masse, Florence, et al.
Publicado: (2019) -
Fabrication and Characterization of Tedizolid Phosphate Nanocrystals for Topical Ocular Application: Improved Solubilization and In Vitro Drug Release
por: Kalam, Mohd Abul, et al.
Publicado: (2022) -
Advances in Nanogels for Topical Drug Delivery in Ocular Diseases
por: Wu, Yongkang, et al.
Publicado: (2023) -
Determining the effect of ocular chemical injuries on topical drug delivery
por: Begum, Ghazala, et al.
Publicado: (2021) -
The Emerging Role of Topical Ocular Drugs to Target the Posterior Eye
por: Wang, Lixiang, et al.
Publicado: (2021)